Showing 1131-1140 of 3877 results for "".
Currents: Eczema
https://practicaldermatology.com/topics/atopic-dermatitis/currents-eczema/23371/Are Municipal Bonds Right for You?
https://practicaldermatology.com/topics/practice-management/are-municipal-bonds-right-for-you/20707/Do they make sense today and are they appropriate if tax rates are positioned to decline?The “Aged Microenvironment”: New Understandings of Melanoma Spread and Aggression
https://practicaldermatology.com/topics/skin-cancer-photoprotection/the-aged-microenvironment-new-understandings-of-melanoma-spread-and-aggression/20863/New research sheds light on pathways through which melanoma may become more aggressive.Recent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments/21805/Assessing Clinical Options for Moderately Dysplastic Nevi Excised with Positive Margins
https://practicaldermatology.com/topics/skin-cancer-photoprotection/assessing-clinical-options-for-moderately-dysplastic-nevi-excised-with-positive-margins/20322/The latest data support the decision to monitor patients rather than re-excise when the pathology report confirms moderate dysplasia with positive margins.New Drugs for Treating Fungal Infections
https://practicaldermatology.com/topics/general-topics/new-drugs-for-treating-fungal-infections/21426/A review of recent developments for efficacious treatment.Recent Developments
https://practicaldermatology.com/topics/practice-management/recent-developments-49/24006/Currents: Patient Engagement And Adherence
https://practicaldermatology.com/topics/practice-management/currents-patient-engagement-and-adherence/23500/Controversies to Take Center Stage at CSF
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/controversies-to-take-center-stage-at-csf/20340/A new venue and new speakers—and a focus on hot topics—will be part of CSF 2018.New Therapeutic Options for the Treatment of Psoriatic Arthritis: IL-17 Blockers
https://practicaldermatology.com/topics/psoriasis/new-therapeutic-options-for-the-treatment-of-psoriatic-arthritis-il-17-blockers/20447/Are TNF inhibitors still the gold standard for PsA?